1082951-17-4 Usage
General Description
2-Amino-1-(4-fluoro-3-(trifluoromethyl)phenyl)ethanone 4-Methylbenzenesulfonate is a chemical compound consisting of an amino ketone and a methylbenzenesulfonate group. The amino ketone portion contains a fluorine-substituted phenyl ring with a trifluoromethyl group attached to it. 2-aMino-1-(4-fluoro-3-(trifluoroMethyl)phenyl)ethanone 4-Methylbenzenesulfonate may have applications in the synthesis of pharmaceuticals, agrochemicals, or other organic compounds due to the presence of the amino and ketone functional groups. The 4-methylbenzenesulfonate group serves as a counterion to the positively charged amino group, enabling the compound to be more stable in solid-state form and enhance its solubility in organic solvents. Overall, this chemical compound may have uses in research and development for various industrial and commercial purposes.
Check Digit Verification of cas no
The CAS Registry Mumber 1082951-17-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,8,2,9,5 and 1 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1082951-17:
(9*1)+(8*0)+(7*8)+(6*2)+(5*9)+(4*5)+(3*1)+(2*1)+(1*7)=154
154 % 10 = 4
So 1082951-17-4 is a valid CAS Registry Number.
InChI:InChI=1S/C16H15F4NO4S/c1-10-2-5-12(6-3-10)26(23,24)25-15(22,9-21)11-4-7-14(17)13(8-11)16(18,19)20/h2-8,22H,9,21H2,1H3
1082951-17-4Relevant articles and documents
Rapid development and scale-up of a 1 H -4-substituted imidazole intermediate enabled by chemistry in continuous plug flow reactors
May, Scott A.,Johnson, Martin D.,Braden, Timothy M.,Calvin, Joel R.,Haeberle, Brian D.,Jines, Amy R.,Miller, Richard D.,Plocharczyk, Edward F.,Rener, Gregory A.,Richey, Rachel N.,Schmid, Christopher R.,Vaid, Radhe K.,Yu, Hannah
experimental part, p. 982 - 1002 (2012/08/27)
The development of reactions in a continuous fashion in plug flow tube reactors (PFR) offers unique advantages to the drug development and scale-up process and can also enable chemistry that would be difficult to perform via batch processing. Herein, we r
P70 S6 KINASE INHIBITORS
-
Page/Page column 63-64, (2009/01/20)
The present invention provides p70 S6 kinase inhibitors of the formula: pharmaceutical formulations comprising them, and methods for their use.